信阳HACCP体系认证

FDA对于美国代理人的解释也可以参考看一下的原文：
Any foreign establishment engaged in the manufacture, preparation, propagation, compounding, or processing of a device imported into the United States must identify a United States agent (U.S. agent) for that establishment.
Information about a foreign establishment’s U.S. Agent is submitted electronically using the FDA Unified Registration and Listing System (FURLS system) and is part of the establishment registration process. Each foreign establishment may designate only one U.S. agent. The foreign establishment may also, but is not required to, designate its U.S. agent as its official correspondent. The foreign establishment should provide the name, address, telephone and fax numbers, and e-mail address of the U.S. agent.
The U.S. agent identified will be required to complete an automated process to confirm that they have agreed to act as the U.S. agent. The automated process will forward an email verification request to the U.S. agent. They will be requested to confirm her/his consent to act as a representative/liaison on behalf of the foreign establishment. If the U.S. agent denies consent (or does not respond within 10 business days), the Official Correspondent/Owner Operator of the foreign establishment will be notified and must designate a new U.S. agent to satisfy the regulatory obligation.
Responsibilities of a U.S. agent
The U.S. agent must either reside in the U.S. or maintain a place of business in the U.S. The U.S. agent cannot use a post office box as an address. The U.S. agent cannot use an answering service. They must be available to answer the phone or have an employee available to answer the phone during normal business hours.
The responsibilities of the U.S. agent are limited and include:
assisting FDA in communications with the foreign establishment,
responding to questions concerning the foreign establishment's devices that are imported or offered for import into the United States,

美国食品药物管理局（FDA）正修订激光产品性能标准的提议向有关方征求意见；评议截止期为 9 月 23 日。该提议旨在：（i） 使当前标准与激光产品和医疗激光产品生产商已使用的国际标准更协调一致；（ii） 降低相关制造商的经济负担；（iii） 增强 FDA 对激光产品的有效性；（iv） 更好地保护和促进公众健康。

目前，美国境内外销售激光产品的生产企业遵守 IEC标准 和 FDA认证的标准。统一这些标准意味着，目前遵守两套不同标准的公司将只需遵守一套标准，除非这些标准有相左之处（如间接辐射限值）。此外，美国FDA也指出这项提议会更好地保护公众健康。该拟议法规将直接影响激光产品生产企业。一般情况下，含有激光或激光系统的所有产品都均需符合当前性能标准。医用激光产品还要符合 FDA 其他医疗设备相关规定。FDA 计划自《联邦纪事》发布之日两年内实施一项终法规。

化妆品FDA认证；FDA化妆品和色素办公室应化妆品工业的要求制定了化妆品自愿注册计划（VCRP）。计划包括两部分：化妆品生产厂家自愿注册和化妆品成分声明。药品、生物制品FDA认证；FDA对医药产品有一整套完整的认证程序以便确保新药的与有效。该程序如下：a、研究性新药申请 （IND）；b、人体实验：人体实验共分4个阶段；c、新药申请 New Drug Application（NDA）、生物制品许可申请 Biologic License Application（BLA）。

时至今日，FDA已成为全球食品药品消费者心中的金刚。FDA认证证明从哪里来很多人会认为FDA是有证书的，然而FDA注册并没有证书。产品在FDA的网站上进行注册，取得注册号码，FDA会给申请人一份回执函；申请注册时需要委托当地企业或是个人团体作为其代理人，负责搭桥连接。FDA本身作为一个执法机构，而非盈利机构，所以FDA既没有面向公众的服务性认证机构与实验室，也没有“实验室”。只对服务性的检测实验室的GMP质量进行认可，合格的颁发证书。FDA不会向任何个人或机构实验室或推荐特定的实验室。

美国进口入境流程：1、在目的港进行FDA的申报，通常由清关行代收件人向美国海关填报入境申请文件，收件人需在FDA注册以及有购买相应的年Bond 资质；2、当FDA接到入境通知后，会通知报关单位以确定是否进行查验，如果无需查验，FDA会向美国海关和进口商发送许可入境通知。不查验，不代表万事大吉，如果日后发现产品违反相关法律法规，将追根溯源且要接受相应惩罚。3、FDA有权决定对产品是否要抽样取证，如需抽样查验，会向美国海关和进口商发查验的通知，调取样品进行查验，会有相应的查验通知及查验结果给到进口商。如终查验结果不合格，除了支付产生的相关费用，货品被没收或是销毁，同时也会被追责。